FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q47604464> ?p ?o ?g. }

• Q47604464 description "2016 nî lūn-bûn" @default.
• Q47604464 description "2016年の論文" @default.
• Q47604464 description "2016年学术文章" @default.
• Q47604464 description "2016年学术文章" @default.
• Q47604464 description "2016年学术文章" @default.
• Q47604464 description "2016年学术文章" @default.
• Q47604464 description "2016年学术文章" @default.
• Q47604464 description "2016年學術文章" @default.
• Q47604464 description "2016年學術文章" @default.
• Q47604464 description "2016年學術文章" @default.
• Q47604464 description "2016年學術文章" @default.
• Q47604464 description "2016年學術文章" @default.
• Q47604464 description "2016年學術文章" @default.
• Q47604464 description "2016년 논문" @default.
• Q47604464 description "article científic" @default.
• Q47604464 description "article scientific" @default.
• Q47604464 description "article scientifique (publié 2016)" @default.
• Q47604464 description "articol științific" @default.
• Q47604464 description "articolo scientifico" @default.
• Q47604464 description "artigo científico (publicado na 2016)" @default.
• Q47604464 description "artigo científico (publicado na 2016)" @default.
• Q47604464 description "artigo científico" @default.
• Q47604464 description "artikull shkencor" @default.
• Q47604464 description "artikulong pang-agham" @default.
• Q47604464 description "artykuł naukowy" @default.
• Q47604464 description "artículo científico publicado en 2016" @default.
• Q47604464 description "artículu científicu" @default.
• Q47604464 description "bilimsel makale" @default.
• Q47604464 description "bài báo khoa học" @default.
• Q47604464 description "mokslinis straipsnis" @default.
• Q47604464 description "naučni članak" @default.
• Q47604464 description "scienca artikolo" @default.
• Q47604464 description "scientific article" @default.
• Q47604464 description "teaduslik artikkel" @default.
• Q47604464 description "tieteellinen artikkeli" @default.
• Q47604464 description "tudományos cikk" @default.
• Q47604464 description "vedecký článok" @default.
• Q47604464 description "vetenskaplig artikel" @default.
• Q47604464 description "videnskabelig artikel (udgivet 2016)" @default.
• Q47604464 description "vitenskapelig artikkel" @default.
• Q47604464 description "vitskapeleg artikkel" @default.
• Q47604464 description "vědecký článek" @default.
• Q47604464 description "wetenschappelijk artikel" @default.
• Q47604464 description "wissenschaftlicher Artikel" @default.
• Q47604464 description "επιστημονικό άρθρο" @default.
• Q47604464 description "мақолаи илмӣ" @default.
• Q47604464 description "мақолаи илмӣ" @default.
• Q47604464 description "наукова стаття, опублікована у вересні 2016" @default.
• Q47604464 description "научна статия" @default.
• Q47604464 description "научная статья" @default.
• Q47604464 description "научни чланак" @default.
• Q47604464 description "научни чланак" @default.
• Q47604464 description "գիտական հոդված" @default.
• Q47604464 description "מאמר מדעי" @default.
• Q47604464 description "سائنسی مضمون" @default.
• Q47604464 description "مقالة علمية" @default.
• Q47604464 description "مقالهٔ علمی" @default.
• Q47604464 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q47604464 description "บทความทางวิทยาศาสตร์" @default.
• Q47604464 description "სამეცნიერო სტატია" @default.
• Q47604464 name "P1.44 (also presented as PD2.02): Phase I/II Trial of X-396, A Novel ALK Inhibitor, in Patients With ALK+ NSCLC: Track: Advanced NSCLC." @default.
• Q47604464 name "P1.44 (also presented as PD2.02): Phase I/II Trial of X-396, A Novel ALK Inhibitor, in Patients With ALK+ NSCLC: Track: Advanced NSCLC." @default.
• Q47604464 type Item @default.
• Q47604464 label "P1.44 (also presented as PD2.02): Phase I/II Trial of X-396, A Novel ALK Inhibitor, in Patients With ALK+ NSCLC: Track: Advanced NSCLC." @default.
• Q47604464 label "P1.44 (also presented as PD2.02): Phase I/II Trial of X-396, A Novel ALK Inhibitor, in Patients With ALK+ NSCLC: Track: Advanced NSCLC." @default.
• Q47604464 prefLabel "P1.44 (also presented as PD2.02): Phase I/II Trial of X-396, A Novel ALK Inhibitor, in Patients With ALK+ NSCLC: Track: Advanced NSCLC." @default.
• Q47604464 prefLabel "P1.44 (also presented as PD2.02): Phase I/II Trial of X-396, A Novel ALK Inhibitor, in Patients With ALK+ NSCLC: Track: Advanced NSCLC." @default.
• Q47604464 P1433 Q47604464-BD39A0CC-E0E5-48CC-AF3C-D451441779B8 @default.
• Q47604464 P1476 Q47604464-F874FE8F-205E-4309-9713-C94351BB5E29 @default.
• Q47604464 P2093 Q47604464-11EC2FBF-AF86-4F85-96D8-AD8C4FCB200D @default.
• Q47604464 P2093 Q47604464-121A520A-E61D-43D6-AB18-48C327749D7F @default.
• Q47604464 P2093 Q47604464-40128B5F-DA1E-402F-A673-C65819F2C8FE @default.
• Q47604464 P2093 Q47604464-51EC8ECE-86FE-4073-9F81-206CB210EC4B @default.
• Q47604464 P2093 Q47604464-53EAC9C5-49D2-4BEE-ACED-C97164F37DEF @default.
• Q47604464 P2093 Q47604464-96BD2ED3-E4DC-483A-BE29-80F238362B40 @default.
• Q47604464 P2093 Q47604464-A3A643A8-3736-4C37-B36D-91197235E271 @default.
• Q47604464 P2093 Q47604464-C1A13183-773A-47BB-BA86-4D75DCC8795F @default.
• Q47604464 P2093 Q47604464-D0F26800-4E9D-40AE-B540-3D9EA3421A2A @default.
• Q47604464 P2093 Q47604464-D617C8EB-8BA7-4842-B977-1446D6E0A3B7 @default.
• Q47604464 P2093 Q47604464-D7B7569E-76AB-467A-8A4A-ECC9232C5CF2 @default.
• Q47604464 P2093 Q47604464-E4965D5B-B614-49B3-886C-C3D438234D98 @default.
• Q47604464 P304 Q47604464-D51CD4EB-801F-4F8A-B5E3-6F686B404650 @default.
• Q47604464 P31 Q47604464-632E6022-904D-4D5D-A9D3-4047B971B8EF @default.
• Q47604464 P356 Q47604464-35FB3730-13B9-4C21-8255-C05BA6195DB1 @default.
• Q47604464 P433 Q47604464-A4AABF8D-460D-4D99-B606-4697BCDA15F3 @default.
• Q47604464 P478 Q47604464-21C0B6AA-4C98-4ECC-B79F-445D1ED8DC77 @default.
• Q47604464 P50 Q47604464-6787107A-C9DD-4669-A416-65614BDDB0DA @default.
• Q47604464 P50 Q47604464-952ECA3B-9119-4147-9D6D-24B3AB3053F9 @default.
• Q47604464 P577 Q47604464-DCBC098C-02B9-443B-8F66-2E1376E0D43B @default.
• Q47604464 P921 Q47604464-020B262A-076F-44B2-A3A7-19F41E10D903 @default.
• Q47604464 P921 Q47604464-75CF22CC-1898-40E7-A226-7608D4021C93 @default.
• Q47604464 P356 J.JTHO.2016.08.066 @default.
• Q47604464 P1433 Q2448056 @default.
• Q47604464 P1476 "P1.44 (also presented as PD2.02): Phase I/II Trial of X-396, A Novel ALK Inhibitor, in Patients With ALK+ NSCLC: Track: Advanced NSCLC." @default.
• Q47604464 P2093 "Chris Liang" @default.
• Q47604464 P2093 "Corey Carter" @default.
• Q47604464 P2093 "Gary Dukart" @default.
• Q47604464 P2093 "Heather Wakelee" @default.
• Q47604464 P2093 "James Gibbons" @default.
• Q47604464 P2093 "Jeffrey Infante" @default.

• next